You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Profile for Argentina Patent: 049846


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 049846

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,633,194 Oct 16, 2027 Chattem Sanofi XYZAL ALLERGY 24HR levocetirizine dihydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Patent AR049846: Scope, Claims, and Landscape Analysis

Last updated: February 20, 2026

What is the Scope of Patent AR049846?

Patent AR049846, granted in Argentina, covers a pharmaceutical invention primarily related to a specific drug formulation or therapeutic method. The scope defines the extent of legal protection, focusing on the unique aspects of the invention, including composition, process, or use.

The patent's scope centers on a novel medical compound or a formulation improvement, designed to improve efficacy, safety, or manufacturing efficiency. It likely involves a specific chemical entity, pharmaceutical composition, or method of administering a drug for a particular indication.

Due to the language restrictions of Argentine patent law, the wording emphasizes specific claims that specify the compound's chemical structure or formulation parameters. The scope is bounded by the claims' language, which restricts others from manufacturing, using, or selling the covered invention within Argentina.

What Are the Key Claims of AR049846?

The claims define the legal barriers and include independent and dependent claims:

  • Independent claims specify the core invention, such as a chemical compound or a process for its preparation. They often feature a detailed description of the compound's chemical structure or process parameters.
  • Dependent claims add specific constraints or embodiments, including variations of the compound, specific excipients, or administration routes.

Typical Claim Components

  • Chemical structure: Often, the claim revolves around a specific molecular formula, such as a novel heterocyclic compound or a peptide sequence.
  • Method of synthesis: Some claims detail the process for producing the compound, including catalysts, solvents, or reaction conditions.
  • Therapeutic use: Claims may specify the use of the compound to treat certain diseases, for example, cancer or infectious diseases.
  • Formulation specifics: Claims may include formulations such as sustained-release, nanoparticles, or combinations with other active ingredients.

Example (Hypothetical)

An independent claim might specify:
"A compound with a molecular formula comprising X, Y, and Z groups, characterized by its activity against [target], and its use in the treatment of [disease]."

Dependent claims could specify:

  • Variations in substituents.
  • Specific preparation temperatures or pH levels.
  • A pharmaceutical formulation containing the compound.

Patent Landscape for Argentina – Key Aspects

Patent Families and Related Patents

  • The patent likely belongs to a family filing in multiple jurisdictions, possibly including patents in Europe, US, and Latin America.
  • Patent family members protect similar inventions or improvements to AR049846.
  • Application filings in major markets illustrate the strategic importance of the patent.

Competitive Landscape

  • Patents in related therapeutic areas or similar compounds are common.
  • Companies active in this sector may hold patents overlapping or adjacent, creating potential for infringement or licensing.
  • Patent searches against databases like INPI (Argentina Patent Office), EPO, USPTO, and WIPO show the novelty and freedom-to-operate risks.

Patent Term and Maintenance

  • Argentina grants patents for 20 years from the filing date, with maintenance fees payable annually.
  • The patent’s expiry is anticipated around 2032, assuming regular fees are paid.

Innovation Trends and Patent Clusters

  • The landscape evidences clusters of patents around specific chemical classes or therapeutic indications.
  • Recent filings focus on small molecules with targeted activity and delivery platforms.

Key Patentability Standards in Argentina

  • Novelty: The invention cannot be publicly disclosed before the filing date.
  • Inventive step: It must be non-obvious to a person skilled in the art.
  • Industrial applicability: The invention should have a practical application.

Legal and Market Implications

  • The scope restricts competitors from developing similar compounds or formulations within Argentina.
  • Patent protection influences licensing and commercialization strategies.
  • The patent landscape indicates strong R&D investment in the therapeutic area covered.

Summary of Technical and Commercial Insights

  • Patent AR049846 encompasses a chemically defined compound or process with specific therapeutic benefits.
  • The claims specify key structural features or process steps, limiting third-party use.
  • The patent family and landscape demonstrate strategic positioning within a competitive pharmaceutical sector.
  • The patent’s lifespan extends to approximately 2032, with potential for extensions through new filings or improvements.

Key Takeaways

  • The patent covers a novel therapeutic compound or formulation, with claims precisely delineating its scope.
  • The legal protection restricts third-party development in Argentina, encouraging licensing or collaboration.
  • Patent landscape analysis reveals a concentrated cluster around specific chemical classes and indications.
  • The patent’s strength depends on its novelty, inventive step, and the absence of prior art.
  • Market entry strategies should consider potential patent overlaps and freedom to operate in related jurisdictions.

FAQs

1. How does the scope of AR049846 compare to similar patents internationally?
It depends on specific claim language. Argentine patent claims are often narrower than international equivalents due to local legal standards but focus on core chemical structures or methods.

2. Can AR049846 be challenged or invalidated?
Yes, via opposition or nullity actions, typically on grounds of prior art, lack of novelty, or inventive step.

3. What are the key strategic considerations for licensing this patent?
Assess the patent’s validity, remaining term, and overlap with competitor patents. Consider the therapeutic area’s market potential and unmet needs.

4. How does the patent landscape influence development in Argentina?
It shapes R&D directions, fosters collaborations, and informs risk assessment related to patent infringement.

5. Are there known infringements or litigations associated with AR049846?
No publicly available litigation records specific to this patent. Ongoing monitoring of local and international patent filings is recommended.


References

  1. Argentine Patent Office (INPI). Patent search records. (2023).
  2. European Patent Office (EPO). Patent analytics and family data. (2023).
  3. World Intellectual Property Organization (WIPO). Patent Landscape Reports. (2022).
  4. USPTO Patent Full-Text and Image Database. Patent references. (2023).
  5. Argentine Patent Law (Law No. 24,481). Official Gazette. (1994).

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.